Atrial fibrillation causes: Difference between revisions
Line 137: | Line 137: | ||
*[[atrial infarction|Atrial ischemia]] | *[[atrial infarction|Atrial ischemia]] | ||
*[[Atrial myxoma]] | *[[Atrial myxoma]] | ||
*[[Atrial septal defect]] | *[[Atrial septal defect]]<ref name="Tikoff-1968">{{Cite journal | last1 = Tikoff | first1 = G. | last2 = Schmidt | first2 = AM. | last3 = Hecht | first3 = HH. | title = Atrial fibrillation in atrial septal defect. | journal = Arch Intern Med | volume = 121 | issue = 5 | pages = 402-5 | month = May | year = 1968 | doi = | PMID = 5645716 }}</ref> | ||
*[[Breath spray which contains alcohol]] | *[[Breath spray which contains alcohol]]<ref name="pmid2914028">{{cite journal| author=Ridker PM, Gibson CM, Lopez R| title=Atrial fibrillation induced by breath spray. | journal=N Engl J Med | year= 1989 | volume= 320 | issue= 2 | pages= 124 | pmid=2914028 | doi= | pmc= | url= }} </ref> | ||
*[[Bronchogenic carcinoma]] | *[[Bronchogenic carcinoma]] | ||
*[[Caffeine]] | *[[Caffeine]] | ||
Line 155: | Line 155: | ||
*[[Coronary artery disease]] | *[[Coronary artery disease]] | ||
*[[Dehydration]] | *[[Dehydration]] | ||
*[[Diabetes]] | *[[Diabetes]]<ref name="Benjamin-1994">{{Cite journal | last1 = Benjamin | first1 = EJ. | last2 = Levy | first2 = D. | last3 = Vaziri | first3 = SM. | last4 = D'Agostino | first4 = RB. | last5 = Belanger | first5 = AJ. | last6 = Wolf | first6 = PA. | title = Independent risk factors for atrial fibrillation in a population-based cohort. The Framingham Heart Study. | journal = JAMA | volume = 271 | issue = 11 | pages = 840-4 | month = Mar | year = 1994 | doi = | PMID = 8114238 }}</ref> | ||
*[[Dilated cardiomyopathy]] | *[[Dilated cardiomyopathy]] | ||
*[[Electrolyte disturbance]] | *[[Electrolyte disturbance]] | ||
Line 163: | Line 163: | ||
*[[Heart failure]] | *[[Heart failure]] | ||
*[[Hemochromatosis]] | *[[Hemochromatosis]] | ||
*[[Hypertensive heart disease]] | *[[Hypertensive heart disease]]<ref name="Krahn-1995">{{Cite journal | last1 = Krahn | first1 = AD. | last2 = Manfreda | first2 = J. | last3 = Tate | first3 = RB. | last4 = Mathewson | first4 = FA. | last5 = Cuddy | first5 = TE. | title = The natural history of atrial fibrillation: incidence, risk factors, and prognosis in the Manitoba Follow-Up Study. | journal = Am J Med | volume = 98 | issue = 5 | pages = 476-84 | month = May | year = 1995 | doi = 10.1016/S0002-9343(99)80348-9 | PMID = 7733127 }}</ref>,<ref name="Kannel-1982">{{Cite journal | last1 = Kannel | first1 = WB. | last2 = Abbott | first2 = RD. | last3 = Savage | first3 = DD. | last4 = McNamara | first4 = PM. | title = Epidemiologic features of chronic atrial fibrillation: the Framingham study. | journal = N Engl J Med | volume = 306 | issue = 17 | pages = 1018-22 | month = Apr | year = 1982 | doi = 10.1056/NEJM198204293061703 | PMID = 7062992 }}</ref> | ||
*[[Hyperthyroidism]] | *[[Hyperthyroidism]] | ||
*[[Hypertrophic cardiomyopathy]] | *[[Hypertrophic cardiomyopathy]]<ref name="Robinson-1990">{{Cite journal | last1 = Robinson | first1 = K. | last2 = Frenneaux | first2 = MP. | last3 = Stockins | first3 = B. | last4 = Karatasakis | first4 = G. | last5 = Poloniecki | first5 = JD. | last6 = McKenna | first6 = WJ. | title = Atrial fibrillation in hypertrophic cardiomyopathy: a longitudinal study. | journal = J Am Coll Cardiol | volume = 15 | issue = 6 | pages = 1279-85 | month = May | year = 1990 | doi = | PMID = 2329232 }}</ref> | ||
<ref name="Cecchi-1995">{{Cite journal | last1 = Cecchi | first1 = F. | last2 = Olivotto | first2 = I. | last3 = Montereggi | first3 = A. | last4 = Santoro | first4 = G. | last5 = Dolara | first5 = A. | last6 = Maron | first6 = BJ. | title = Hypertrophic cardiomyopathy in Tuscany: clinical course and outcome in an unselected regional population. | journal = J Am Coll Cardiol | volume = 26 | issue = 6 | pages = 1529-36 | month = Nov | year = 1995 | doi = 10.1016/0735-1097(95)00353-3 | PMID = 7594081 }}</ref> | |||
*[[Hypothermia]] | *[[Hypothermia]] | ||
*[[Hypothyroidism]] | *[[Hypothyroidism]] | ||
Line 172: | Line 173: | ||
*[[Lung cancer]] | *[[Lung cancer]] | ||
*[[Lutembacher syndrome]] | *[[Lutembacher syndrome]] | ||
*[[Methamphetamines]] | *[[Methamphetamines]] | ||
*[[Mitral regurgitation]] | *[[Mitral regurgitation]]<ref name="Grigioni-2002">{{Cite journal | last1 = Grigioni | first1 = F. | last2 = Avierinos | first2 = JF. | last3 = Ling | first3 = LH. | last4 = Scott | first4 = CG. | last5 = Bailey | first5 = KR. | last6 = Tajik | first6 = AJ. | last7 = Frye | first7 = RL. | last8 = Enriquez-Sarano | first8 = M. | title = Atrial fibrillation complicating the course of degenerative mitral regurgitation: determinants and long-term outcome. | journal = J Am Coll Cardiol | volume = 40 | issue = 1 | pages = 84-92 | month = Jul | year = 2002 | doi = | PMID = 12103260 }}</ref> | ||
*[[Mitral stenosis]] | *[[Mitral stenosis]] | ||
*[[Myocardial infarction]] | *[[Myocardial infarction]]<ref name="Zimetbaum-2000">{{Cite journal | last1 = Zimetbaum | first1 = PJ. | last2 = Josephson | first2 = ME. | last3 = McDonald | first3 = MJ. | last4 = McClennen | first4 = S. | last5 = Korley | first5 = V. | last6 = Ho | first6 = KK. | last7 = Papageorgiou | first7 = P. | last8 = Cohen | first8 = DJ. | title = Incidence and predictors of myocardial infarction among patients with atrial fibrillation. | journal = J Am Coll Cardiol | volume = 36 | issue = 4 | pages = 1223-7 | month = Oct | year = 2000 | doi = | PMID = 11028474 }}</ref> | ||
*[[Myocarditis]] | *[[Myocarditis]] | ||
*[[Obstructive sleep apnea]] | *[[Obstructive sleep apnea]] | ||
Line 188: | Line 188: | ||
*[[Pulmonary hypertension]] | *[[Pulmonary hypertension]] | ||
*[[Renal insufficiency]] | *[[Renal insufficiency]] | ||
*[[Rheumatic heart disease]] | *[[Rheumatic heart disease]]<ref name="Grigioni-2002">{{Cite journal | last1 = Grigioni | first1 = F. | last2 = Avierinos | first2 = JF. | last3 = Ling | first3 = LH. | last4 = Scott | first4 = CG. | last5 = Bailey | first5 = KR. | last6 = Tajik | first6 = AJ. | last7 = Frye | first7 = RL. | last8 = Enriquez-Sarano | first8 = M. | title = Atrial fibrillation complicating the course of degenerative mitral regurgitation: determinants and long-term outcome. | journal = J Am Coll Cardiol | volume = 40 | issue = 1 | pages = 84-92 | month = Jul | year = 2002 | doi = | PMID = 12103260 }}</ref> | ||
*[[Sarcoidosis]] | *[[Sarcoidosis]] | ||
*[[Stroke]] | *[[Stroke]] |
Revision as of 19:59, 13 August 2013
Atrial Fibrillation Microchapters | |
Special Groups | |
---|---|
Diagnosis | |
Treatment | |
Cardioversion | |
Anticoagulation | |
Surgery | |
Case Studies | |
Atrial fibrillation causes On the Web | |
Risk calculators and risk factors for Atrial fibrillation causes | |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
The most common cause of atrial fibrillation is atrial dilation associated with hypertension. Approximately 1/3 of patients have familial atrial fibrillation which is due to an underlying genetic disorder. Given the number of patients who undergo coronary artery bypass grafting in the developed world, this is an increasing underlying cause of atrial fibrillation. Other general causes include the advancing age of the population this hemodynamic stress of heart failure and valvular heart disease, myocardial ischemia, a variety of inflammatory disorders, pulmonary diseases, alcohol and drug abuse, and endocrine disorders.
Causes
Common Causes
- COPD
- Drugs
- Hypertension
- MI
- Sick sinus syndrome
- Sleep apnea
- Stress
- Thyrotoxicosis
- Valvular heart disease
Causes by Organ System
Causes in Alphabetical Order
- Acute myocardial infarction
- Alcohol
- Alcohol withdrawal
- Atrial ischemia
- Atrial myxoma
- Atrial septal defect[2]
- Breath spray which contains alcohol[1]
- Bronchogenic carcinoma
- Caffeine
- Cardiac tumors
- Cardiomyopathy
- Channelopaties
- Chronic kidney disease
- Chronic obstructive pulmonary disease
- Cocaine
- Collagen vascular disease
- Congenital heart disease
- Congestive heart failure
- Conivaptan
- Constrictive pericarditis
- Coronary artery bypass graft surgery
- Coronary artery disease
- Dehydration
- Diabetes[3]
- Dilated cardiomyopathy
- Electrolyte disturbance
- Endocarditis
- Familial atrial fibrillation
- Fatigue
- Heart failure
- Hemochromatosis
- Hypertensive heart disease[4],[5]
- Hyperthyroidism
- Hypertrophic cardiomyopathy[6]
- Hypothermia
- Hypothyroidism
- Hypoxia
- Left ventricular hypertrophy
- Lung cancer
- Lutembacher syndrome
- Methamphetamines
- Mitral regurgitation[8]
- Mitral stenosis
- Myocardial infarction[9]
- Myocarditis
- Obstructive sleep apnea
- Pericarditis
- Peripartum cardiomyopathy
- Pheochromocytoma
- Pneumonia
- Porfimer sodium
- Psychological stress
- Pulmonary embolism
- Pulmonary hypertension
- Renal insufficiency
- Rheumatic heart disease[8]
- Sarcoidosis
- Stroke
- Subarachnoid hemorrhage
- Surgery
- Tricuspid regurgitation
- Tricuspid stenosis
- Unstable angina
- Uremic pericarditis
- Valvular heart disease
- Viral infections
Lone Atrial Fibrillation
In about 10% of patients no underlying cause is identified. This condition is called lone atrial fibrillation.
References
- ↑ 1.0 1.1 1.2 Ridker PM, Gibson CM, Lopez R (1989). "Atrial fibrillation induced by breath spray". N Engl J Med. 320 (2): 124. PMID 2914028.
- ↑ Tikoff, G.; Schmidt, AM.; Hecht, HH. (1968). "Atrial fibrillation in atrial septal defect". Arch Intern Med. 121 (5): 402–5. PMID 5645716. Unknown parameter
|month=
ignored (help) - ↑ Benjamin, EJ.; Levy, D.; Vaziri, SM.; D'Agostino, RB.; Belanger, AJ.; Wolf, PA. (1994). "Independent risk factors for atrial fibrillation in a population-based cohort. The Framingham Heart Study". JAMA. 271 (11): 840–4. PMID 8114238. Unknown parameter
|month=
ignored (help) - ↑ Krahn, AD.; Manfreda, J.; Tate, RB.; Mathewson, FA.; Cuddy, TE. (1995). "The natural history of atrial fibrillation: incidence, risk factors, and prognosis in the Manitoba Follow-Up Study". Am J Med. 98 (5): 476–84. doi:10.1016/S0002-9343(99)80348-9. PMID 7733127. Unknown parameter
|month=
ignored (help) - ↑ Kannel, WB.; Abbott, RD.; Savage, DD.; McNamara, PM. (1982). "Epidemiologic features of chronic atrial fibrillation: the Framingham study". N Engl J Med. 306 (17): 1018–22. doi:10.1056/NEJM198204293061703. PMID 7062992. Unknown parameter
|month=
ignored (help) - ↑ Robinson, K.; Frenneaux, MP.; Stockins, B.; Karatasakis, G.; Poloniecki, JD.; McKenna, WJ. (1990). "Atrial fibrillation in hypertrophic cardiomyopathy: a longitudinal study". J Am Coll Cardiol. 15 (6): 1279–85. PMID 2329232. Unknown parameter
|month=
ignored (help) - ↑ Cecchi, F.; Olivotto, I.; Montereggi, A.; Santoro, G.; Dolara, A.; Maron, BJ. (1995). "Hypertrophic cardiomyopathy in Tuscany: clinical course and outcome in an unselected regional population". J Am Coll Cardiol. 26 (6): 1529–36. doi:10.1016/0735-1097(95)00353-3. PMID 7594081. Unknown parameter
|month=
ignored (help) - ↑ 8.0 8.1 Grigioni, F.; Avierinos, JF.; Ling, LH.; Scott, CG.; Bailey, KR.; Tajik, AJ.; Frye, RL.; Enriquez-Sarano, M. (2002). "Atrial fibrillation complicating the course of degenerative mitral regurgitation: determinants and long-term outcome". J Am Coll Cardiol. 40 (1): 84–92. PMID 12103260. Unknown parameter
|month=
ignored (help) - ↑ Zimetbaum, PJ.; Josephson, ME.; McDonald, MJ.; McClennen, S.; Korley, V.; Ho, KK.; Papageorgiou, P.; Cohen, DJ. (2000). "Incidence and predictors of myocardial infarction among patients with atrial fibrillation". J Am Coll Cardiol. 36 (4): 1223–7. PMID 11028474. Unknown parameter
|month=
ignored (help)